These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
200 related items for PubMed ID: 19942121
21. Balancing benefit against risk in the choice of therapy for coronary artery disease. Lesson from prospective, randomized, clinical trials of percutaneous coronary intervention and coronary artery bypass graft surgery. Morrison DA, Sacks J. Minerva Cardioangiol; 2003 Oct; 51(5):585-97. PubMed ID: 14551526 [Abstract] [Full Text] [Related]
22. Treatment of double vessel coronary artery disease by totally endoscopic bypass surgery and drug-eluting stent placement in one simultaneous hybrid session. Bonatti J, Schachner T, Bonaros N, Jonetzko P, Ohlinger A, Löckinger A, Stalzer B, Eschertzhuber S, Friedrich G. Heart Surg Forum; 2005 Oct; 8(4):E284-6. PubMed ID: 16112943 [Abstract] [Full Text] [Related]
23. Multivessel percutaneous coronary intervention: a new paradigm for a new century. Morrison DA. Minerva Cardioangiol; 2005 Oct; 53(5):361-77. PubMed ID: 16179881 [Abstract] [Full Text] [Related]
24. Minimally invasive coronary artery bypass grafting in high-risk patients. Late follow-up with assessment of left internal mammary artery graft patency and flow by exercise transthoracic Doppler echocardiography. Sunderdiek U, Kalweit GA, Marx R, Schipke JD, Gams E. Cardiovasc Surg; 2003 Oct; 11(5):389-95. PubMed ID: 12958550 [Abstract] [Full Text] [Related]
25. Drug-eluting stents for the percutaneous treatment of the anastomosis of the left internal mammary graft to left anterior descending artery. Zavalloni D, Rossi ML, Scatturin M, Morenghi E, Soregaroli D, Municino A, Gasparini GL, Lisignoli V, Barbaro C, Presbitero P. Coron Artery Dis; 2007 Sep; 18(6):495-500. PubMed ID: 17700223 [Abstract] [Full Text] [Related]
26. Revascularization of left anterior descending artery with drug-eluting stents: comparison with minimally invasive direct coronary artery bypass surgery. Ben-Gal Y, Mohr R, Braunstein R, Finkelstein A, Hansson N, Hendler A, Moshkovitz Y, Uretzky G. Ann Thorac Surg; 2006 Dec; 82(6):2067-71. PubMed ID: 17126111 [Abstract] [Full Text] [Related]
27. PCI versus CABG for multivessel coronary disease in diabetics. Tarantini G, Ramondo A, Napodano M, Favaretto E, Gardin A, Bilato C, Nesseris G, Tarzia V, Cademartiri F, Gerosa G, Iliceto S. Catheter Cardiovasc Interv; 2009 Jan 01; 73(1):50-8. PubMed ID: 19089938 [Abstract] [Full Text] [Related]
28. Revascularization in the high-risk patient: multivessel disease. Onuma Y, Daemen J, Kukreja N, Serruys P. Minerva Cardioangiol; 2007 Oct 01; 55(5):579-92. PubMed ID: 17912164 [Abstract] [Full Text] [Related]
29. Clinical and angiographic results after hybrid coronary revascularization. Halkos ME, Walker PF, Vassiliades TA, Douglas JS, Devireddy C, Guyton RA, Finn AV, Rab ST, Puskas JD, Liberman HA. Ann Thorac Surg; 2014 Feb 01; 97(2):484-90. PubMed ID: 24140212 [Abstract] [Full Text] [Related]
30. Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: a meta-analysis with 5-year patient-level data from the ARTS, ERACI-II, MASS-II, and SoS trials. Daemen J, Boersma E, Flather M, Booth J, Stables R, Rodriguez A, Rodriguez-Granillo G, Hueb WA, Lemos PA, Serruys PW. Circulation; 2008 Sep 09; 118(11):1146-54. PubMed ID: 18725490 [Abstract] [Full Text] [Related]
31. Multivessel coronary revascularization in patients with and without diabetes mellitus: 3-year follow-up of the ARTS-II (Arterial Revascularization Therapies Study-Part II) trial. Daemen J, Kuck KH, Macaya C, LeGrand V, Vrolix M, Carrie D, Sheiban I, Suttorp MJ, Vranckx P, Rademaker T, Goedhart D, Schuijer M, Wittebols K, Macours N, Stoll HP, Serruys PW, ARTS-II Investigators. J Am Coll Cardiol; 2008 Dec 09; 52(24):1957-67. PubMed ID: 19055986 [Abstract] [Full Text] [Related]
32. Nonrandomized comparison of coronary artery bypass surgery and percutaneous coronary intervention for the treatment of unprotected left main coronary artery disease in octogenarians. Rodés-Cabau J, Deblois J, Bertrand OF, Mohammadi S, Courtis J, Larose E, Dagenais F, Déry JP, Mathieu P, Rousseau M, Barbeau G, Baillot R, Gleeton O, Perron J, Nguyen CM, Roy L, Doyle D, De Larochellière R, Bogaty P, Voisine P. Circulation; 2008 Dec 02; 118(23):2374-81. PubMed ID: 19029471 [Abstract] [Full Text] [Related]
33. Current clinical outcomes of percutaneous coronary intervention and coronary artery bypass grafting. Mack MJ, Prince SL, Herbert M, Brown PP, Katz M, Palmer G, Edgerton JR, Eichhorn E, Magee MJ, Dewey TM. Ann Thorac Surg; 2008 Aug 02; 86(2):496-503; discussion 503. PubMed ID: 18640323 [Abstract] [Full Text] [Related]
34. 10-year follow-up of a prospective randomized trial comparing bare-metal stenting with internal mammary artery grafting for proximal, isolated de novo left anterior coronary artery stenosis the SIMA (Stenting versus Internal Mammary Artery grafting) trial. Goy JJ, Kaufmann U, Hurni M, Cook S, Versaci F, Ruchat P, Bertel O, Pieper M, Meier B, Chiarello L, Eeckhout E, SIMA Investigators. J Am Coll Cardiol; 2008 Sep 02; 52(10):815-7. PubMed ID: 18755343 [Abstract] [Full Text] [Related]
35. Meta-analysis of four randomized controlled trials on long-term outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with stenting for multivessel coronary artery disease. Takagi H, Kawai N, Umemoto T. Am J Cardiol; 2008 May 01; 101(9):1259-62. PubMed ID: 18435954 [Abstract] [Full Text] [Related]
36. Does reasonable incomplete surgical revascularization affect early or long-term survival in patients with multivessel coronary artery disease receiving left internal mammary artery bypass to left anterior descending artery? Rastan AJ, Walther T, Falk V, Kempfert J, Merk D, Lehmann S, Holzhey D, Mohr FW. Circulation; 2009 Sep 15; 120(11 Suppl):S70-7. PubMed ID: 19752389 [Abstract] [Full Text] [Related]
37. Minimally invasive coronary artery bypass grafting. Acuff TE, Landreneau RJ, Griffith BP, Mack MJ. Ann Thorac Surg; 1996 Jan 15; 61(1):135-7. PubMed ID: 8561539 [Abstract] [Full Text] [Related]
38. "Hybrid" and combined percutaneous and surgical intervention to treat selected cardiac patients: a new strategy. Presbitero P, Gallotti R, Belli G, Franciosi G, Maiello L, Nicolini F, Manasse E, Citterio E, Carcagnì A, Foresti A. G Ital Cardiol; 1999 Jan 15; 29(1):27-33. PubMed ID: 9987044 [Abstract] [Full Text] [Related]
39. Current percutaneous coronary intervention and coronary artery bypass grafting practices for three-vessel and left main coronary artery disease. Insights from the SYNTAX run-in phase. Kappetein AP, Dawkins KD, Mohr FW, Morice MC, Mack MJ, Russell ME, Pomar J, Serruys PW. Eur J Cardiothorac Surg; 2006 Apr 15; 29(4):486-91. PubMed ID: 16497510 [Abstract] [Full Text] [Related]
40. [Impact of drug-eluting stents on transferring treatment with coronary surgical revascularization among patients initially admitted to department of internal medicine]. He LQ, Ma CS, Nie SP, Lü Q, Jia CQ, DU X, Liu XH, Dong JZ, Li ZZ, Chen F, Zhou YJ, Lü SZ, Wu XS. Zhonghua Yi Xue Za Zhi; 2007 Jun 12; 87(22):1518-22. PubMed ID: 17785099 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]